Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor
- PMID: 2784485
- PMCID: PMC2189229
- DOI: 10.1084/jem.169.4.1323
Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor
Abstract
A mouse hybridoma cell line, TU27, producing an mAb was established. TU27 mAb reacted with various human and Gibbon ape T cell lines bearing the IL-2R p75 (IL-2Rp75), but not with cell lines expressing only Tac antigen, IL-2Rp55, and numbers of its binding sites on cell surfaces were similar to those of high-affinity IL-2R. Radioimmunoprecipitation with TU27 mAb defined a molecule with a molecular mass of 75 kD on the surface of IL-2Rp75 bearing cells. TU27 mAb completely blocked IL-2 binding to IL-2Rp75 and to the high-affinity IL-2R but not to IL-2Rp55 composing the low-affinity IL-2R. The IL-2-dependent growth of a human T cell line, ILT-Mat, was significantly inhibited by TU27 mAb only at low concentrations of IL-2, and combination of TU27 mAb and H-31 mAb specific for IL-2Rp55 completely inhibited the cell growth even at high concentrations of IL-2. These data strongly suggest that TU27 mAb is specific for the human IL-2Rp75.
Similar articles
-
IL-2 receptor subunit, p75: direct demonstration of its IL-2 binding ability by using a novel monoclonal antibody.Int Immunol. 1989;1(4):373-7. doi: 10.1093/intimm/1.4.373. Int Immunol. 1989. PMID: 2489034
-
Synergistic action of monoclonal antibodies directed at p55 and p75 chains of the human IL-2-receptor.J Immunol. 1991 Feb 1;146(3):884-92. J Immunol. 1991. PMID: 1988501
-
The evidence for the IL-2 receptor beta chain processing from p70 to p75.Int Immunol. 1990;2(5):469-72. doi: 10.1093/intimm/2.5.469. Int Immunol. 1990. PMID: 2128185
-
Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells.J Immunol. 1989 Dec 1;143(11):3548-55. J Immunol. 1989. PMID: 2584707
-
The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation.Environ Health Perspect. 1987 Nov;75:11-5. doi: 10.1289/ehp.877511. Environ Health Perspect. 1987. PMID: 2891501 Free PMC article. Review.
Cited by
-
Immunotherapy through the IL-2 receptor.Immunol Res. 1992;11(1):42-53. doi: 10.1007/BF02918607. Immunol Res. 1992. PMID: 1602182 Review. No abstract available.
-
Activation of natural killer cells via the p75 interleukin 2 receptor.J Exp Med. 1989 Jul 1;170(1):291-6. doi: 10.1084/jem.170.1.291. J Exp Med. 1989. PMID: 2787381 Free PMC article.
-
Human immunodeficiency virus-infected adherent cell-derived inhibitory factor (p29) inhibits normal T cell proliferation through decreased expression of high affinity interleukin-2 receptors and production of interleukin-2.J Clin Invest. 1992 Jul;90(1):8-14. doi: 10.1172/JCI115859. J Clin Invest. 1992. PMID: 1321845 Free PMC article.
-
The augmentation of lymphokine-activated killer activity following pulsing of human peripheral blood mononuclear cells with recombinant human interleukin-2.Cancer Immunol Immunother. 1992;35(4):264-70. doi: 10.1007/BF01789333. Cancer Immunol Immunother. 1992. PMID: 1511461 Free PMC article.
-
Physical association of JAK1 and JAK2 tyrosine kinases with the interleukin 2 receptor beta and gamma chains.Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7271-5. doi: 10.1073/pnas.91.15.7271. Proc Natl Acad Sci U S A. 1994. PMID: 8041779 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous